Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mack Roach

Showing results (121-130 of 284) with videos related to

Pageof 29
Sort By:
Investigational New Drugs|September 14, 2020
Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancerBenjamin A Gartrell, Mack Roach, Avi Retter, et al.
Biomedicines|September 28, 2021
Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)Iván Henríquez, Mack Roach, Todd M Morgan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapySten Myrehaug, Gordon Chan, Tim Craig, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Prostate movement during simulation resulting from retrograde urethrogram compared with "natural" prostate movementYu-Ming Liu, Stella Ling, K M Langen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2003
(Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging deviceJean Pouliot, Michele Aubin, Katja M Langen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2004
Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imagingBarby Pickett, Randall K Ten Haken, John Kurhanewicz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experienceBrian Lee, Katsuto Shinohara, Vivian Weinberg, et al.
Brachytherapy|December 24, 2014
Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapyDavid R Raleigh, I-Chow Hsu, Steve Braunstein, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2006
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceMack Roach, Gerald Hanks, Howard Thames, et al.
Brachytherapy|September 23, 2011
Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapyJ Adam M Cunha, Jean Pouliot, Vivian Weinberg, et al.
Pageof 29

Showing results (121-130 of 284) with videos related to

Sort By:
Pageof 29
Investigational New Drugs|September 14, 2020
Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancerBenjamin A Gartrell, Mack Roach, Avi Retter, et al.
Biomedicines|September 28, 2021
Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)Iván Henríquez, Mack Roach, Todd M Morgan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapySten Myrehaug, Gordon Chan, Tim Craig, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Prostate movement during simulation resulting from retrograde urethrogram compared with "natural" prostate movementYu-Ming Liu, Stella Ling, K M Langen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2003
(Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging deviceJean Pouliot, Michele Aubin, Katja M Langen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2004
Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imagingBarby Pickett, Randall K Ten Haken, John Kurhanewicz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experienceBrian Lee, Katsuto Shinohara, Vivian Weinberg, et al.
Brachytherapy|December 24, 2014
Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapyDavid R Raleigh, I-Chow Hsu, Steve Braunstein, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2006
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceMack Roach, Gerald Hanks, Howard Thames, et al.
Brachytherapy|September 23, 2011
Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapyJ Adam M Cunha, Jean Pouliot, Vivian Weinberg, et al.
Pageof 29